Steve Kirsch - Substack
I write about COVID mitigation policies, vaccines, corruption, censorship, and early treatments. The data shows that vaccines are ruining the health of Americans and driving the epidemic in a variety of health conditions.
Steve Kirsch - Wikipedia
Steven Todd Kirsch is an American entrepreneur. He has started several companies and was one of two independent inventors of the optical mouse. Kirsch has been both a philanthropic supporter of medical research, and a promoter of misinformation about COVID-19 vaccines.
Tech millionaire Steve Kirsch went from covid trial funder to ...
2021年10月5日 · After boosting unproven covid drugs like fluvoxamine and ivermectin and campaigning against vaccines, Steve Kirsch was abandoned by his team of scientific advisers—and left out of a job.
Anti-vaccine activists are building a legal network : NPR
2023年5月4日 · Steve Kirsch, a tech entrepreneur turned anti-vaccine activist, at a conference in Atlanta for future COVID and vaccine-related litigation that he helped organize and fund.
This tech millionaire went from covid trial funder to ...
2022年11月28日 · In the early days of the pandemic, as billions of dollars poured into the hunt for novel treatments and vaccines, veteran Silicon Valley entrepreneur Steve Kirsch did what he’s always done: He went looking for an underdog.
Steve Kirsch's newsletter | Substack
2024年1月7日 · Click to read Steve Kirsch's newsletter, a Substack publication with hundreds of thousands of subscribers. I write about COVID mitigation policies, vaccines, corruption, censorship, and early treatments.
About the Founders - Kirsch Foundation
Steve Kirsch, 50, is founder and chairman of Propel Software and CEO of Abaca, both Silicon Valley start-ups. He is, however, perhaps best known as the founder and chairman of Infoseek Corporation, an Internet navigation service that was acquired by the Walt Disney Company in November 1999.
Silicon Valley entrepreneur Steve Kirsch urges the FDA to ...
2021年3月30日 · Last March, as the Silicon Valley tech community abandoned open offices for working at home, tech entrepreneur Steve Kirsch turned his attention, startup skills, and available cash to finding a cure—or at least a solid treatment—for COVID-19.
Steve Kirsch, Founder of the Covid-19 Early Treatment Fund
COVID-19 Early Treatment Fund founder Steve Kirsch joins Aaron to discuss why he started the world's only organization 100% focused on funding the most promising drugs and treatments for COVID-19.
Steve Kirsch Home page
By Steve Kirsch Mar 21, 2021 Fluvoxamine, Proxalutamide, and Ivermectin: 100% success I'm very bullish on two drug combos since it is rare for a single drug to be 100% successful.